Leading Nifedipine Companies in Vietnam | Key Players 2026

Leading Nifedipine Companies in Vietnam

The following is a data-backed list of the leading Vietnam Nifedipine companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the Vietnam Nifedipine Industry, including DHG Pharmaceutical Joint Stock Company, Pymepharco Joint Stock Company, and other established names.

List of Nifedipine companies in Vietnam:

1. DHG Pharmaceutical Joint Stock Company

DHG Pharma leverages its position as a leading domestic manufacturer to provide essential, high-quality cardiovascular medications to the Vietnamese population.

2. Pymepharco Joint Stock Company

Pymepharco focuses on modernizing its GMP-certified production lines to deliver effective generic cardiovascular treatments to hospitals nationwide.

3. Imexpharm Corporation

Imexpharm emphasizes EU-GMP quality standards to produce reliable generic formulations that support the management of chronic hypertensive conditions.

4. Vidipha Central Pharmaceutical Joint Stock Company

Vidipha contributes to market accessibility by providing affordable, high-standard essential medicines for cardiovascular disease management across Vietnam.

5. Pfizer Inc.

Pfizer maintains a strong clinical presence in Vietnam, supporting the healthcare system with established calcium channel blocker solutions and global expertise.

6. Novartis (Sandoz)

Sandoz utilizes its extensive global generic portfolio to offer effective and cost-competitive Nifedipine options that align with international safety standards.

7. Bayer AG

Bayer remains a prominent global leader in cardiovascular research, providing advanced, long-acting Nifedipine formulations widely trusted by Vietnamese cardiologists.

8. Viatris Inc.

Viatris supports the cardiovascular sector through a diverse range of specialty drugs designed to enhance the long-term management of chronic conditions.

9. Teva Pharmaceutical Industries Ltd.

Teva enhances market reach by supplying essential cardiac-active medications to a wide network of regional healthcare facilities and pharmacies.

10. Gedeon Richter Plc.

Gedeon Richter focuses on the delivery of high-purity pharmaceutical products, playing a key role in supplying therapeutic options for the cardiovascular patient base.

Frequently Asked Questions About the Market Study (FAQs):